Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Rankning i aktier #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Aktiekurs
$7.15
Marknadsvärde
$313.60M
Förändring (1 dag)
-2.12%
Förändring (1 år)
-84.14%
Land
DE
Handel Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategori

Historik för aktiesplit för Anbio Biotechnology Class A Ordinary Shares (NNNN)
Aktien Anbio Biotechnology Class A Ordinary Shares (symbol: NNNN) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Sep 02, 2026.
En NNNN-aktie köpt före Sep 02, 2026 motsvarar nu 0 NNNN-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH